These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31901038)

  • 41. Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?
    Pasmant E; Parfait B; Luscan A; Goussard P; Briand-Suleau A; Laurendeau I; Fouveaut C; Leroy C; Montadert A; Wolkenstein P; Vidaud M; Vidaud D
    Eur J Hum Genet; 2015 May; 23(5):596-601. PubMed ID: 25074460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Genetic Study and Prenatal Diagnosis of a Family with Thrombocytopenia-Absent Radius (TAR) Syndrome].
    Ding L; Huang YZ; Qian YQ; Dong MY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):711-715. PubMed ID: 34323054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification and characterization of NF1 splicing mutations in Korean patients with neurofibromatosis type 1.
    Jang MA; Kim YE; Kim SK; Lee MK; Kim JW; Ki CS
    J Hum Genet; 2016 Aug; 61(8):705-9. PubMed ID: 27074763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deep Intronic LINE-1 Insertions in
    Alesi V; Genovese S; Lepri FR; Catino G; Loddo S; Orlando V; Di Tommaso S; Morgia A; Martucci L; Di Donato M; Digilio MC; Dallapiccola B; Novelli A; Capolino R
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical variability of neurofibromatosis 1: A modifying role of cooccurring PTPN11 variants and atypical brain MRI findings.
    D'Amico A; Rosano C; Pannone L; Pinna V; Assunto A; Motta M; Ugga L; Daniele P; Mandile R; Mariniello L; Siano MA; Santoro C; Piluso G; Martinelli S; Strisciuglio P; De Luca A; Tartaglia M; Melis D
    Clin Genet; 2021 Nov; 100(5):563-572. PubMed ID: 34346503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.
    Messiaen LM; Callens T; Mortier G; Beysen D; Vandenbroucke I; Van Roy N; Speleman F; Paepe AD
    Hum Mutat; 2000; 15(6):541-55. PubMed ID: 10862084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-yield identification of pathogenic NF1 variants by skin fibroblast transcriptome screening after apparently normal diagnostic DNA testing.
    Douben HCW; Nellist M; van Unen L; Elfferich P; Kasteleijn E; Hoogeveen-Westerveld M; Louwen J; van Veghel-Plandsoen M; de Valk W; Saris JJ; Hendriks F; Korpershoek E; Hoefsloot LH; van Vliet M; van Bever Y; van de Laar I; Aten E; Lachmeijer AMA; Taal W; van den Bersselaar L; Schuurmans J; Oostenbrink R; van Minkelen R; van Ierland Y; van Ham TJ
    Hum Mutat; 2022 Dec; 43(12):2130-2140. PubMed ID: 36251260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
    Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
    Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Genoa experience of prenatal diagnosis in NF1.
    Origone P; Bonioli E; Panucci E; Costabel S; Ajmar F; Coviello DA
    Prenat Diagn; 2000 Sep; 20(9):719-24. PubMed ID: 11015700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor LOH analysis provides reliable linkage information for prenatal genetic testing of sporadic NF1 patients.
    Serra E; Pros E; García C; López E; Gili ML; Gómez C; Ravella A; Capellá G; Blanco I; Lázaro C
    Genes Chromosomes Cancer; 2007 Sep; 46(9):820-7. PubMed ID: 17563086
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spinal neurofibromatosis in a family with classical neurofibromatosis type 1 and a novel NF1 gene mutation.
    Nicita F; Torrente I; Spalice A; Bottillo I; Papetti L; Pinna V; Ursitti F; Ruggieri M
    J Clin Neurosci; 2014 Feb; 21(2):328-30. PubMed ID: 23954459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience.
    Sabbagh A; Pasmant E; Imbard A; Luscan A; Soares M; Blanché H; Laurendeau I; Ferkal S; Vidaud M; Pinson S; Bellanné-Chantelot C; Vidaud D; Parfait B; Wolkenstein P
    Hum Mutat; 2013 Nov; 34(11):1510-8. PubMed ID: 23913538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prenatal diagnosis and genetic counseling of X-linked Alport syndrome in China].
    Zhang HW; Ding J; Wang F; Yang HX
    Zhonghua Er Ke Za Zhi; 2007 Jul; 45(7):484-9. PubMed ID: 17953801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Illegitimate splicing of the NF1 gene in healthy individuals mimics mutation-induced splicing alterations in NF1 patients.
    Wimmer K; Eckart M; Rehder H; Fonatsch C
    Hum Genet; 2000 Mar; 106(3):311-3. PubMed ID: 10798360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type 1.
    Pacot L; Pelletier V; Chansavang A; Briand-Suleau A; Burin des Roziers C; Coustier A; Maillard T; Vaucouleur N; Orhant L; Barbance C; Lermine A; Hamzaoui N; Hadjadj D; Laurendeau I; El Khattabi L; Nectoux J; Vidaud M; Parfait B; Dollfus H; Pasmant E; Vidaud D
    Hum Genet; 2023 Jan; 142(1):1-9. PubMed ID: 35941319
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two independent mutations in a family with neurofibromatosis type 1 (NF1).
    Klose A; Peters H; Hoffmeyer S; Buske A; Lüder A; Hess D; Lehmann R; Nürnberg P; Tinschert S
    Am J Med Genet; 1999 Mar; 83(1):6-12. PubMed ID: 10076878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
    Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation study.
    Maruoka R; Takenouchi T; Torii C; Shimizu A; Misu K; Higasa K; Matsuda F; Ota A; Tanito K; Kuramochi A; Arima Y; Otsuka F; Yoshida Y; Moriyama K; Niimura M; Saya H; Kosaki K
    Genet Test Mol Biomarkers; 2014 Nov; 18(11):722-35. PubMed ID: 25325900
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [COL7A1 gene mutation analysis of dystrophic epidermolysis bullosa and prenatal diagnosis].
    Liu N; Guo H; Kong X; Shi H; Yang Y; Wu Q; Zhao Z; Jiang M
    Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(4):277-82. PubMed ID: 25877244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical characteristics and mutation Spectrum of NF1 in 12 Chinese families with orbital/periorbital plexiform Neurofibromatosis type 1.
    Chai P; Luo Y; Zhou C; Wang Y; Fan X; Jia R
    BMC Med Genet; 2019 Sep; 20(1):158. PubMed ID: 31533651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.